RE:RE:From the FDA
Cardu.. no. But anyway, we won't get RTF.
The only decision IMO now is priority review or standard review. For me, cancer treatmens with unmet medical need alone = PR.
And the US investors... who invests such a big number of capital before a (actually) fifty-fifty decision? the us boys must be convinced. the trend is your friend - look - TST accumulated at a partly dreadful market.